Expand TLSA Menu
TLSA MENU

TLSA Latest Press Releases

-- April 16, 2026 --

Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-CD3 Antibody Attenuates Long COVID Neuroinflammation and Improves Cognitive Function Globe Newswire 7:00 AM

-- April 14, 2026 --

Tiziana Life Sciences Announces Late Breaking Poster Accepted for Presentation at the 7th World Parkinson Congress Globe Newswire 7:00 AM

-- April 1, 2026 --

Tiziana Announces Data Showing Nasal Anti-CD3 Improves Cognition Associated with Aging Globe Newswire 7:00 AM

-- February 25, 2026 --

Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates CSF Inflammation, Upregulates Neuroprotective Pathways, and Correlates with Reduced Microglial Activation on PET Scans in na-SPMS Patients with PIRA Globe Newswire 7:00 AM

-- January 20, 2026 --

Tiziana Life Sciences Announces the Peer-Reviewed Publication of Clinical Study Results for Intranasal Foralumab Globe Newswire 11:15 AM

-- January 16, 2026 --

Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares Globe Newswire 2:45 PM
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $17.6 Million Globe Newswire 7:00 AM

-- January 9, 2026 --

Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco Globe Newswire 7:00 AM

-- December 29, 2025 --

Tiziana Files Annual Safety Report for Intranasal Foralumab with FDA Globe Newswire 8:00 AM

-- December 19, 2025 --

Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman Globe Newswire 11:00 AM

-- December 17, 2025 --

Tiziana Life Sciences to Ring the Closing Bell at Nasdaq Globe Newswire 10:00 AM
Tiziana Life Sciences Doses First Patient in Phase 2 Alzheimer's Clinical Trial Globe Newswire 8:45 AM

-- December 15, 2025 --

Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer Globe Newswire 3:07 PM
Tiziana Life Sciences Announces Withdrawal of Proposed Public Offering Globe Newswire 7:30 AM

-- December 12, 2025 --

Tiziana Life Sciences to Dose First Patient in Phase 2 Alzheimer's Trial Globe Newswire 2:10 PM

-- December 2, 2025 --

Tiziana Life Sciences Plans to Spinout IL-6 Asset into Separate Listed Company Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes